India  /  Published 17.10.20

Blow to two drugs used in India to fight Covid

By G.S. Mudur in New Delhi

India  /  Published 22.08.20

HCQ: study on health staff

Private health researchers have announced plans for a study on 7,000 healthcare workers across India to determine whether the anti-malarial drug hydroxychloroquine can lower the risk of the coronaviru...
By G.S. Mudur in New Delhi

India  /  Published 18.08.20

Covid: Academic sting fools journal

A team of European scientists has orchestrated a sting operation on an academic journal in India by claiming in a paper that the anti-malarial drug hydroxychloroquine can prevent push-scooter accident...
By G.S. Mudur in New Delhi

India  /  Published 05.06.20

Record spike of 9,851 cases in 24 hrs, tally now 2,26,770

Elderly man commits suicide over fear of contracting virusThe fear of contracting Covid-19 infection allegedly led a 65-year-old man to commit suicide in Maharashtra's Beed district, police said on Fr...
By PTI in New Delhi

India  /  Published 13.06.20

Advice against HCQ in severe cases

India’s department of health research on Saturday recommended against the use of the anti-malarial hydroxychloroquine on patients with severe coronavirus disease and introduced three still-experimen...
By G.S. Mudur in New Delhi

India  /  Published 10.04.20

Enough HCQ tablets for domestic use: Centre

India has decided to supply hydroxychloroquine, an anti-malarial drug now used to treat Covid-19 patients, to the US and multiple other countries after ensuring that there are sufficient stocks for do...
By G.S. Mudur in New Delhi

Business  /  Published 10.04.20

Bengal Chem to make drug

The Bengal government’s directorate of drugs control on Friday gave its approval to Bengal Chemicals and Pharmaceuticals Ltd to produce hydroxychloroquine tablets.The public sector undertaking will...
By A Staff Reporter in Calcutta

India  /  Published 10.04.20

Decision to bring Indians from abroad to be taken after review

Over 20,400 foreign nationals have been evacuated from India and a decision on bringing Indians from abroad will be taken at a later stage after reviewing the COVID-19 situation, the government said o...
By PTI in New Delhi

India  /  Published 07.04.20

Trump warns of 'retaliation' if India doesn't export anti-malaria drug

American President Donald Trump has warned India that the US may retaliate if it did not export anti-malarial drug Hydroxychloroquine despite his personal request, saying he would be surprised in case...
By PTI in Washington

India  /  Published 06.04.20

Malaria drug use in Covid not for public

The Union health ministry on Monday cautioned that its recommendation of the anti-malarial hydroxychloroquine as a preventive medication only for healthcare workers and household contacts of Covid-19 ...
By G.S. Mudur in New Delhi


Download our latest App

to get update on the go...


Copyright © 2020 The Telegraph. All rights reserved.